Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
10.67
+0.15 (1.43%)
Dec 20, 2024, 4:00 PM EST - Market closed
Bioventus Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$15.00
Upside
+40.58%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Sell → Hold Upgrades $12 → $13 | Sell → Hold | Upgrades | $12 → $13 | +21.84% | Dec 17, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $15 | Strong Buy | Maintains | $12 → $15 | +40.58% | Nov 6, 2024 |
Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $17 | Strong Buy | Maintains | $12 → $17 | +59.33% | Sep 27, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $8 → $12 | Strong Buy | Maintains | $8 → $12 | +12.46% | Aug 13, 2024 |
Craig-Hallum | Craig-Hallum | Strong Buy Maintains $9 → $12 | Strong Buy | Maintains | $9 → $12 | +12.46% | Aug 7, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | -25.02% | May 8, 2024 |
Craig-Hallum | Craig-Hallum | Strong Buy Maintains $6 → $9 | Strong Buy | Maintains | $6 → $9 | -15.65% | Mar 13, 2024 |
Canaccord Genuity | Canaccord Genuity | Hold → Strong Buy Upgrades $3.66 → $7 | Hold → Strong Buy | Upgrades | $3.66 → $7 | -34.40% | Dec 7, 2023 |
Craig-Hallum | Craig-Hallum | Hold Maintains $10 → $5 | Hold | Maintains | $10 → $5 | -53.14% | Apr 3, 2023 |
Goldman Sachs | Goldman Sachs | Hold Maintains $13 → $2.5 | Hold | Maintains | $13 → $2.5 | -76.57% | Nov 30, 2022 |
Craig-Hallum | Craig-Hallum | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 22, 2022 |
Morgan Stanley | Morgan Stanley | Buy Maintains $11 → $5 | Buy | Maintains | $11 → $5 | -53.14% | Nov 10, 2022 |
Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 9, 2022 |
JP Morgan | JP Morgan | Buy → Sell Downgrades n/a | Buy → Sell | Downgrades | n/a | n/a | Nov 9, 2022 |
Morgan Stanley | Morgan Stanley | Buy Maintains $12 → $11 | Buy | Maintains | $12 → $11 | +3.09% | Oct 11, 2022 |
Goldman Sachs | Goldman Sachs | Hold Maintains $15 → $13 | Hold | Maintains | $15 → $13 | +21.84% | Sep 7, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.